共 50 条
- [21] RETRACTED: Clinical Importance of Somatostatin Receptor 2 (SSTR2) and Somatostatin Receptor 5 (SSTR5) Expression in Thyrotropin-Producing Pituitary Adenoma (TSHoma) (Retracted Article) [J]. MEDICAL SCIENCE MONITOR, 2017, 23 : 1947 - 1955
- [25] Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes SSTR2 and SSTR5 through different mechanisms [J]. Proceedings of the National Academy of Sciences of the United States of America, 1995, 92 (05):
- [28] 2 AMINO-ACIDS, LOCATED IN TRANSMEMBRANE DOMAIN-VI AND DOMAIN-VII, DETERMINE THE SELECTIVITY OF THE PEPTIDE AGONIST SMS-201-995 FOR THE SSTR2 SOMATOSTATIN RECEPTOR [J]. EMBO JOURNAL, 1995, 14 (04): : 727 - 735